In one longitudinal study, complement effect proteins C4b, C3d, Factor B, Bb, C3b, and C5b-C9 TCC increased in blood ADsEVs of patients with AD, while complement regulatory proteins CD59 and DAF decreased, consistent with the directional changes observed in NDsEVs. This evidence concerns the gene CD55 and Alzheimer disease.